Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPOWER: Patient vs Provider-led Insulin Titration in GDM
NCT05922033Phase 4Completed
- Sponsor
- The Ohio State University
- Start
- Oct 2023
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in gestational diabetes mellitus (GDM), sponsored by The Ohio State University. Started Oct 2023; status: completed.
02
Drugs
human insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT05922033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05922033.